2
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Lithium Salts Adopted for Psychopharmacological Use as the Modulators of Protein Synthesis in the Brain: Analytical Review

Pages 1-6 | Received 19 Nov 1987, Published online: 07 Jul 2009

References

  • Radar L. I., Simonyan T. T. On the experience of clinical application of several Lithium salts in a complex therapy of post-insult conditions complicated with an endogenous depression. Psychoneurology 1987; 12: 88–96
  • Aslanbekov A. N., Ragimov I. O., Beroyev S. T., Tsalagov R. K. Clinical use of the Lithium salts. I. Maniacal syndromes. Proceedings of the Soviet Association of Neuropathologists and Psychiatrists 1986; 34: 889–895
  • Aslanbekov A. N., Ragimov I. O., Tsalagov R. K., Godzhijev U. D. Clinical use of the Lithium salts. II. Endogenous depressions. Proceedings of the Soviet Association of Neuropathologists and Psychiatrists 1987; 35: 23–38
  • Berdyshev K. L., Makeyev L. U. Biochemical study of protein synthesis activity in vivo and in vitro in the presence of Lithium salts. Progress in Biochemical Medicine (Jena) 1986; 5: 651–657
  • Bowell J. J., Saldift H., Harth G. P., Lawrence G. F., Mathews E. C. Lithium salts as a specific modulator of protein synthesis rate in vitro and in vivo. A neurochemical approach. Applied Neurobiology 1985; 9: 344–356
  • Dollerthy W. Lithium in the selective prevention of several mental diseases. The comparative analysis of numerous case reports. Clinical Psychopharmacology 1982; 23: 761–777
  • Kamysheva R. P., Kotlyar N. B., Vartanyan L. L., Sormov T. E. Prothrombin deficiency in psychiatric patients treated with different types of the Lithium salts. Soviet Medicine 1980; 65: 554–569
  • Kolomin G. K., Gordinskaya T. R. The evaluation of a possible protein synthesis inhibition or activation induced by the Lithium salts in a model biochemical experiment. Methods in Neurochemistry 1983; 16: 90–101
  • Kostandov I. P., Kochev T. A., Lambrev G. F., Mitchev G. S. Lithium carbonate effect on the translation rate in vitro and in vivo. Acta Neurobiologica et Neuropathologica 1984; 10: 883–889
  • Kuznetsov D. A., Zavijalov N. V., Govorkov A. V., Sibileva T. M. Methyl mercury induced nonselective blocking of phosphorylation process as a possible cause of protein synthesis inhibition in vitro and in vivo. Toxicology Letters 1987; 36: 153–160
  • Lapin R. R., Shkuro Z. B., Boldyreva D. D., Timovich G. P., Sologub K. U., Feodorov N. N. Lithium oxybutyrate: Clinical and biochemical study of the efficiency of the drug in psychiatric patients with a primary endogenous depression developed after the survival in the cases of an acute ischaemic insult. Mental Health (Prague) 1987; 2: 67–88
  • Malyshev R. P., Prokolova G. S., Aushev G. R., Zamchuk I. I. Lithium hydrocarbonate as an inhibitor of protein synthesis in mammalian tissues. USSR Journal of General Pathology 1985; 44: 1211–1220
  • Molodkin L. A., Frolov F. R., Sakharova D. E., Zakhariya O. I. On the mechanisms of a therapeutic effect of the Lithium salts as a special agent for pharmacoprevention of maniacal conditions. Experimental Pharmacotherapy 1987; 4: 971–985
  • Nemeroff N., Dahl P. S. J. Study of the distribution of the Lithium inside the protein synthesizing machinery elements isolated from the brain tissue of different species of the mammals. General and Clinical Biochemistry 1986; 33: 702–712
  • Novak J., Jostek H. A comparison of a danger extent of several types of psychotropic therapeutical agents adopted for a clinical use in the CSSR. Trends in Mental Health Protection 1984; 8: 122–139
  • Revella T. V., Giazzotti G., Bertalucci F. Clinical pharmacology of Lithium salts. A review. Advances in Preventive Psychiatry 1979; 6: 34–56
  • Sabirov U. G., Gnezdyansky K. K. Toxicological evaluation of different inorganic salts of the Lithium adopted and recommended for clinical use in the USSR. Middle Asian Medical Journal 1977; 39: 651–669
  • Savina O. J. On the changes of prothrombin level in the blood of psychiatric adult patients in the course of a long-term treatment with different types of the Lithium preparations. N. I. Pirogov School of Medicine Research Communications (Moscow) 1980; 48: 540–553
  • Shurov L. J., Gorin E. R. On the revealing of biochemical interactions of the Lithium cations. Journal of Prophylactical Medicine 1985; 20: 311–321
  • Sinitsky V. N. The depression diseases. Naukova Dumka Publishers, Kiev 1986; 212–239
  • Solomon H., Blatcher L. G., Crouchet J., Beaud P. γ-Oxybutyrate biological effects with a special reference to neurophysiological aspects. Neuropathology and Neurosurgery 1980; 11: 911–920
  • Souvereques J. B. Lithium preparations in modern psychiatry. Archives of Psychiatry 1987; 125: 789–799
  • Speransky L. I., Lvov K. O., Pluzhnikova T. M., Fokin R. S. Several new Lithium preparations in experimental psychopharmacology. Recent developments and perspectives. Public Health in the USSR 1986; 63: 45–67
  • Vestengauz G. P., Schvernik I. O., Brestler R. A., Stetsenko R. F., Droboglav V. V. Lithium orthophosphate effect on the rate of protein synthesis processed in vivo and in several types of cell-free translation systems. Bulletin of the Patrice Lumumba University (Moscow) 1985; 56: 437–446

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.